Paper Information

Journal:   INTERNATIONAL JOURNAL OF REPRODUCTIVE BIOMEDICINE (IRANIAN JOURNAL OF REPRODUCTIVE MEDICINE)   September 2016 , Volume 14 , Number 9; Page(s) 577 To 582.
 
Paper: 

Imatinib alters cell viability but not growth factors levels in TM4 Sertoli cells

 
 
Author(s):  HASHEMNIA SEYYED MOHAMMAD REZA, ATARI HAJIPIRLOO SOMAYEH, ROSHAN MILANI SHIVA, VALIZADEH NASIM, Mahabadi sonya, KHERADMAND FATEMEH*
 
* Department of Biochemistry, Cellular Molecular and Solid Tumor Research Centers, Urmia University of Medical Sciences, Pardis Nazloo, 11th Km. Sero (Nazloo) Road, Urmia, Iran
 
Abstract: 
Background: The anticancer agent imatinib (IM) is a small molecular analog of ATP that inhibits tyrosine kinase activity of platelet derived growth factors (PDGFs) and stem cell factor (SCF) receptor in cancer cells. However these factors have a key role in regulating growth and development of normal Sertoli, Leydig and germ cells. Objective: The aim of this study was to determine cell viability, PDGF and SCF levels in mouse normal Sertoli cells exposed to IM. Materials and Methods: In this experimental study, the mouse TM4 Sertoli cells were treated with 0, 2. 5, 5, 10 and 20 μ M IM for 2, 4 or 6 days. The cell viability and growth factors levels were assessed by MTT and ELISA methods, respectively. For statistical analysis, One-Way ANOVA was performed. Results: IM showed significant decrease in Sertoli cell viability compared to control group (p=0. 001). However, IM increased PDGF and SCF level insignificantly (p>0. 05). Conclusion: Results suggested that IM treatment induced a dose dependent reduction of cell viability in Sertoli cells. It seems that treatment with this anticancer drug is involved in the fertility process. Further studies are needed to evaluate the role of PDGF and SCF in this cell. Key
 
Keyword(s): Cell viability,Imatinib mesylate,Sertoli cells,Platelet derived growth factor,Stem cell factor
 
References: 
  • ندارد
 
  pdf-File tarjomyar Yearly Visit 31
 
Latest on Blog
Enter SID Blog